Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 78 results for "biocon"

Cipla lowers bio drugs investment, sharpens focus on respiratory

Cipla lowers bio drugs investment, sharpens focus on respiratory

MUMBAI: Cipla Ltd, India's fifth-largest drugmaker by sales, plans to reduce investment in biosimilars to sharpen its focus on building a portfolio of high-margin respiratory products, the company's chief executive said on Thursday. It has put plans to build ... Sify, 2 days ago

120 images for biocon

Money Control, 3 days ago
Money Control, 2 weeks ago
Money Control, 1 week ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Today, 4 weeks ago
Sify, 4 weeks ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control, 2 months ago

CCI order against Roche is anti-competition: HC

The Delhi High Court on Wednesday termed as "anti-competition and anti-legal right", a Competition Commission of India's (CCI) order initiating an inquiry into the alleged abuse of dominant position by Swiss drug major Roche. Justice Sanjeev Sachdeva said the ...
 The Financial Chronicle3 days ago

Pharma stocks see heavy selling pressure, down up to 6%

Pharma stocks today witnessed heavy selling pressure, falling up to 6 per cent in an overall weak broader market. Shares of Aurobindo Pharma tumbled 5.94 per cent, Orchid Pharma tanked 5.57 per cent, Cipla went down by 4.89 per cent and Morepen Lab (4.76 per ...
 Business Standard4 days ago

CRS to inspect Metro north-south line on May 24, may open in June

The Commissioner of Railway Safety (CRS) will inspect Namma Metro's Sampige Road-Yelachenahalli line on May 24 and if all goes well, the government will open it for public in the first week of June, Bengaluru Development Minister K J George said on Wednesday.
 Deccan Herald1 week ago
Money Control

Biocon shares dip 4% on USFDA observations

Shares of biotechnology major Biocon fell by over 4 per cent today after the company received observations from the US health regulator pertaining to issues over manufacturing practices. The scrip declined 4.06 per cent to close at Rs 1,004.45 on BSE. During ...
 Business Standard2 weeks ago Biocon slips after USFDA observations  Business Standard2 weeks ago Received observations from USFDA, responded to all: Biocon  DNA2 weeks ago Biocon falls over 5% after US FDA issues 8 observations for Bengaluru unit  Money Control2 weeks ago
Money Today

EXCLUSIVE: Biocon open to ‘unlocking value’ in units after 5 years; may look at MA

Biocon chairperson Kiran Mazumdar-Shaw told Moneycontrol that the company is focusing on ramping up its biologics business, which accounts for 15 percent of overall revenues, but has the potential to be a game changer.
 Money Control4 weeks ago Biocon's adjusted Q4 net profit up; company issues bonus shares  Money Today4 weeks ago Biocon Q4 net up 75% at Rs 135 cr  Business Standard4 weeks ago Biocon surges 5% on bonus issue plan  Business Standard1 month ago

Biocon consolidated net profit declines 61.71% in the March 2017 quarter

Sales decline 1.53% to Rs 919.20 crore
 Business Standard4 weeks ago Biocon standalone net profit rises 58.23% in the March 2017 quarter  Business Standard4 weeks ago
Money Control

CCI rules in favour of Biocon in case against Roche over breast cancer drug

Biocon and Mylan started marketing biosimilars of Roche's Trastuzumab drug in 2014
 Business Standard1 month ago Biocon to sell Parit in India after Eisai ends 12-year partnership with GSK  Money Control1 month ago Biocon partners with Eisai to markets its anti-ulcer drug in India  Money Control2 months ago Biocon, Mylan breast cancer drugs approved by DCGI: HC told  Money Control2 months ago

Board of Biocon recommends final dividend

Of Rs 3 per share
 Business Standard4 weeks ago Biocon to consider recommendation of final dividend  Money Control1 month ago
Money Control

Top buzzing midcap stocks to trade on April 25

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- BHEL, MM, Rallis, Biocon, Indiabulls Housing Finance, Marksans Pharma, MCX, Alembic Pharma, Delta Corp, and Pincon Spirits.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less